PUBLISHER: The Business Research Company | PRODUCT CODE: 2127349
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127349
An in vitro fertilization device is a specialized piece of medical equipment designed to facilitate the fertilization of eggs with sperm outside the human body under carefully controlled laboratory conditions. These devices provide accurate regulation of temperature, humidity, gas composition, and sterile conditions that are essential for embryo development and handling throughout fertility procedures. An in vitro fertilization device is used for embryo culture, sperm preparation, egg retrieval support, and microscopic examination to enhance the efficiency and precision of assisted reproductive technologies.
The primary product types of in vitro fertilization devices include incubators, cryosystems, imaging systems, ovum aspiration pumps, micromanipulators, and other product categories. Incubators are specialized devices designed to maintain controlled environmental conditions that support embryo development during in vitro fertilization procedures. These devices are offered in manual in vitro fertilization systems, semi-automated systems, and fully automated or time-lapse platforms. Their primary applications include fresh embryo transfer, intracytoplasmic sperm injection, and pre-implantation genetic testing, while the major end users are fertility clinics, hospitals, clinical research laboratories, cryobanks, and academic institutes.
Tariffs are influencing the in vitro fertilization device market by increasing the cost of imported precision laboratory equipment, cryogenic storage solutions, imaging systems, and micromanipulation instruments required for assisted reproductive procedures. This is disrupting purchasing cycles and slowing the expansion of IVF laboratories, particularly in import-dependent regions such as Asia-Pacific and Latin America where fertility clinics rely extensively on global suppliers for advanced reproductive technologies. High-value segments including time-lapse incubators, electronic ovum aspiration pumps, and embryo imaging systems are experiencing the greatest effects because of their dependence on sophisticated semiconductor technologies and precision engineering supply chains. However, tariffs are encouraging localized production of IVF laboratory equipment, broader supplier diversification, and increased investment in regional biomedical device ecosystems, ultimately strengthening long-term supply chain resilience and supporting cost optimization strategies across the market.
The in vitro fertilization device market research report is one of a series of new reports from The Business Research Company that provides in vitro fertilization device market statistics, including in vitro fertilization device industry global market size, regional shares, competitors with a in vitro fertilization device market share, detailed in vitro fertilization device market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro fertilization device industry. This in vitro fertilization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The in vitro fertilization device market size has grown strongly in recent years. It will grow from $20.44 billion in 2025 to $22.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising infertility prevalence, expansion of fertility clinics globally, improvement in ivf success rates over time, introduction of basic embryo culture and lab systems, increasing awareness of assisted reproductive technologies.
The in vitro fertilization device market size is expected to see strong growth in the next few years. It will grow to $31.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising delayed parenthood trends, increasing government reimbursement and insurance coverage, expansion of fertility tourism across regions, growing demand in emerging economies, increasing adoption of cryopreservation for fertility preservation. Major trends in the forecast period include single embryo transfer adoption and elective single embryo transfer protocols, expanded fertility preservation demand and social egg freezing adoption, rising ivf treatment affordability and insurance coverage expansion, standardization of lab quality control and contamination prevention protocols, increasing demand for portable and modular ivf lab setups in emerging markets.
The increasing rates of infertility among couples are expected to accelerate the growth of the in vitro fertilization device market in the coming years. Infertility among couples refers to the inability to achieve pregnancy after a defined period of regular, unprotected sexual activity. The growing prevalence of infertility is driven by factors such as delayed parenthood, as more individuals are choosing to start families at older ages when natural fertility levels decline. In vitro fertilization devices assist couples facing infertility by providing advanced laboratory instruments and precise technological systems that enhance fertilization procedures, support embryo development, and improve the overall efficiency of assisted reproductive treatments. For example, in August 2025, according to the Office for National Statistics (ONS), a UK government department, the total fertility rate (TFR) in England and Wales remained at a record low of 1.41 children per woman in 2024, compared with 1.42 in 2023, indicating the continued decline in fertility rates and the increasing challenges associated with infertility. Therefore, the rising infertility rates among couples are supporting the growth of the in vitro fertilization device market.
Leading companies operating in the in vitro fertilization device market are focusing on developing advanced products such as embryo and oocyte vitrification and storage devices to enhance cryopreservation efficiency, improve embryo viability, and increase the success rates of assisted reproductive procedures. Embryo and oocyte vitrification and storage devices are specialized IVF systems that rapidly freeze and securely preserve embryos and eggs, maintaining their viability and quality for future fertility treatments. For example, in October 2024, Cook Medical, a US-based medical device company, launched the NestVT, a vitrification and storage device for embryos and oocytes. It improves the safe vitrification, cryo-storage, and handling of embryos and oocytes during IVF procedures, enhancing specimen stability and supporting efficient fertility treatment workflows. The NestVT vitrification device features a fully enclosed design that helps prevent oocytes and embryos from coming into direct contact with liquid nitrogen during cryopreservation.
In October 2023, Hamilton Thorne Ltd., a US-based manufacturer of medical equipment, acquired Gynetics Medical Products N.V. and Gynetics Services B.V. for an undisclosed amount. Through this acquisition, Hamilton Thorne aimed to enhance its IVF consumables portfolio, strengthen its footprint in the European assisted reproductive technology (ART) market, and broaden its range of embryo transfer catheters, ovum pick-up needles, and other IVF laboratory and clinical products. Gynetics Medical Products N.V. is a Belgium-based producer of advanced in vitro fertilization (IVF) devices and consumables supplied to fertility clinics across the globe.
Major companies operating in the in vitro fertilization device market report are ASB Medical System, Carl Zeiss AG, CooperSurgical Inc., Cryologic Pty Ltd., Esco Medical, Eppendorf SE, FertiPro N.V., IVFsynergy Ltd., Kitazato Corporation, LEEC Limited, MedGyn Products Inc., Merck KGaA, Minitube International AG, Narishige Co. Ltd., Nikon Instruments Inc., NidaCon International AB, Planer Ltd., RI.MOS. S.r.l., Sperm Processor Pvt. Ltd., The Baker Company Inc., Thermo Fisher Scientific, Vitrolife AB, Vitromed Healthcare
North America was the dominating region in the in vitro fertilization device market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the in vitro fertilization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the in vitro fertilization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in vitro fertilization device market consists of sales of microscopes, embryo transfer catheters, embryo culture dishes, sperm separation devices, and laminar flow cabinets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In Vitro Fertilization Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses in vitro fertilization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for in vitro fertilization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro fertilization device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.